Zhao Y, Griesel R, Omar Z, Simmons B, et al. Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a non-comparative, double-blind, randomised placebo-controlled trial. Clin Infect Dis 2023 Jan 16:ciad023. doi: 10.1093.
PMID: 36645792